Mikael Oerum
Founder at Ventac Partners LLC
Profile
Mikael Oerum founded Ventac Partners LLC in 2002, where he is working as Partner from 2002.
Mr. Oerum also currently works at Orbit Genomics, Inc., as Chairman, Cenexum Technologies ApS, as Chairman from 2022, Qmed Consulting Group, as Chairman from 2023, IXALTIS SAS, as Board Member from 2021, and CUBE Labs Srl, as Strategic Advisory Board Member from 2021.
Mr. Oerum also formerly worked at Coegin Pharma AB, as Chairman & CEO from 2005 to 2019, Lifandis AS, as Chairman from 2011 to 2015, Medicon Valley Alliance FMBA, as Vice Chairman from 2000 to 2014, Regenesance BV, as Chairman from 2009 to 2011, CASiGEN Pharma Ltd., as Chairman from 2012 to 2016, Neuroscience Technologies Ltd., as Chairman of the Board of Directors from 2010 to 2020, RhoVac AB, as Chairman from 2014 to 2019, Amunix Pharmaceuticals, Inc., as Chairman from 2017 to 2018, Idogen AB, as Board of Director from 2014 to 2017, Technical University of Denmark, as Advisory Board Member from 2002 to 2012, and APIM Therapeutics AS, as Board Member from 2009 to 2011.
Mikael Oerum active positions
| Companies | Position | Start |
|---|---|---|
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Consultant / Advisor | 01/11/2021 |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Director/Board Member | 01/11/2021 |
| Ventac Partners LLC | Founder | 01/07/2002 |
Orbit Genomics, Inc.
 Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Chairman | - |
| Cenexum Technologies ApS | Chairman | 01/05/2022 |
Former positions of Mikael Oerum
| Companies | Position | End |
|---|---|---|
| Neuroscience Technologies Ltd. | Director/Board Member | 02/04/2020 |
| CHOSA ONCOLOGY AB | Chairman | 31/10/2019 |
| COEGIN PHARMA AB | Chief Executive Officer | 31/07/2019 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Chairman | 01/05/2018 |
| ░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IDOGEN AB (PUBL) | Health Technology |
| COEGIN PHARMA AB | Health Technology |
| Private companies | 13 |
|---|---|
Lifandis AS
 Lifandis AS Internet Software/ServicesTechnology Services Lifandis AS provides access to a wealth of biological samples. It offers data and biological material from the HUNT studies. The company was founded in 2007 and is headquartered in Levanger, Norway. | Technology Services |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region. | Commercial Services |
Regenesance BV
 Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | Retail Trade |
| CASiGEN Pharma Ltd. | |
| Ventac Partners LLC | |
| Neuroscience Technologies Ltd. | |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Health Technology |
CUBE Labs Srl
CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Finance |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
Orbit Genomics, Inc.
Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Technology Services |
| Cenexum Technologies ApS |
- Stock Market
- Insiders
- Mikael Oerum
